News
Agilent to Acquire Dako for $2.2 Billion
May 17, 2012 - Acquisition is Next Step in Agilent's Growing Role in Clinical Diagnostics.
Merck Revenues Increase 3.2% to €2.6 Billion
May 15, 2012 - The Merck Group’s first-quarter 2012 total revenues rose 3.2% to €2,645 million compared to €2,564 million in the first quarter of 2011.
NautaDutilh and Niaba map red biotech
May 14, 2012 - NautaDutilh and Niaba have published a report that maps the market expectations in the Dutch biotechnology industry.
LS associations continue LSH portal and weekly
National cluster organisation Life Sciences & Health has terminated its activities on April 27.
UvA and VU sign intention to collaborate
May 11, 2012 - VU and UvA will sign a letter of intent for stronger collaboration.
Abbott to Acquire PhIIb drug from Action Pharma
May 3, 2012 - Abbott and Action Pharma A/S, a privately owned company, announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.
New tax regulation R&D
On May 1st the new tax regulation Research & Development Aftrek (Deduction) has taken effect.
Cloud for faster research
April 26, 2012 - BT is introducing BT for Life Sciences, a cloud service developed to enhance the R&D productivity in the life sciences industry through cooperation.
EMA maintains recommendation not to grant marketing authorisation for Glybera
April 20, 2012 - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) at its April 2012 meeting maintained its recommendation not to grant a marketing authorisation for the orphan medicine Glybera (alipogene tiparvovec), from Amsterdam Molecular Therapeutics.
Dissolution AMT complete
April 5, 2012 - Amsterdam Molecular Therapeutics (AMT) announces completion of disposal of its operations to uniQure B.V. and its dissolution becoming effective.
Orientation paper KP7 Health published
April 4, 2012 - The European Commission has published the orientation paper for the last call of the KP7 theme Health.
Innovation contracts signed: €195M for life sciences
April 2, 2012 - Industry, knowledge institutes and government have signed the innovation contracts, making available €2,8 billion in 2012 for research and development of innovative products and services in the economic topsectors.
